2 Breakout Growth Stocks Worth Buying Today

Venturesome, young investors should nibble on Nuvei (TSX:NVEI) and another Canadian growth stock if they seek superior growth over the extremely long run.

| More on:

High-multiple growth stocks could be prime targets of the next market selloff if the U.S. Federal Reserve aggressively moves the needle higher on rates. While many top hyper-growth stocks are pretty frothy at these levels, with valuation metrics heavily tilted on the higher end of the historical range, I think it’s unfair to label them all as overvalued or overdue for a crash.

Undoubtedly, high-multiple stocks are most vulnerable to the biggest swoons to the downside. But on the flip side, many emerging firms may be more than capable of growing into their sky-high multiples. Shopify, an expensive stock that’s commanded a high multiple for many years, fits the bill as a firm that’s continued to raise the bar on itself. The stock has plunged many times in the past. But at the end of the day, shares continued higher, and those who weren’t startled out of the name by extreme levels of volatility were to ones who walked away with incredible results.

At this critical crossroads, investors seem split, with one camp favouring value, and the other, innovative growth plays. In this piece, we’ll have two high-risk growth stocks for the latter camp.

Docebo

Docebo (TSX:DCBO)(NASDAQ:DCBO) was one of my best-performing picks last year. Shares of the Learning Management System (LMS) software developer are currently breaking out to new all-time highs just south of $100 per share. After surging nearly 800% since its March 2020 lows, it’s tough to justify buying shares here. The next selloff could have the potential to be absolutely ridiculous. And it could happen if Docebo misses the mark for a quarter or if the broader basket of bid-up high-multiple tech stocks plunges again due to exogenous factors.

At 30.4 times sales, the stock is frothy. Given the promising fundamentals, however, the name is hardly a bubble. Unlike many other high-multiple stocks, Docebo has an incredibly innovative product with a unique offering and a massive total addressable market. Indeed, the $3.1 billion company’s AI solution is a great offering that’s tough for other tech companies to replicate.

Docebo has been and will continue to be my top pick to play the digital transformation of the workplace. The valuation is steep, and although I’d be inclined to take profits after a massive multi-bagger move, I’d say it may be a better idea to leave your stake alone. The company has, in one way or another, found a way to raise an already high bar. Until there’s a prominent stumble or growth slowdown, it’ll be tough to break up with the breakout cloud stock.

Nuvei

Nuvei (TSX:NVEI) is my top Canadian way to play the booming payments scene. After nearly tripling off its first close just under a year ago, shares are riding high on some considerable momentum. But it’s momentum that I believe could be sustained, as the Montreal-based company continues falling on the radars of tech investors who seek to invest on the cutting edge of innovation.

Just over a week ago, Nuvei revealed an incredible second-quarter beat (114% year-over-year revenue growth) — its fourth straight. For Nuvei, it seems like the beats keep getting bigger and bigger. And while it will eventually stumble, I don’t think that moment will be anytime soon.

With shares trading at over 28 times sales, Nuvei, like Docebo, is very much vulnerable to the next market-wide pullback. For venturesome investors, though, I’m certainly not against getting some skin in the game today, as the stock’s continued rally may very well dwarf the next correction, whenever it may be.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor Joey Frenette has no position in any of the stocks mentioned. The Motley Fool owns shares of and recommends Docebo Inc.

More on Tech Stocks

Man data analyze
Tech Stocks

3 Reasons Celestica Stock Is a Screaming Buy Now

These three reasons make Celestica stock a screaming buy for long-term investors.

Read more »

profit rises over time
Dividend Stocks

These 2 Dow Stocks Are Set to Soar in 2025 and Beyond

Two Dow Jones stocks are screaming buys but Canadians must hold them in an RRSP or RRIF to avoid paying…

Read more »

telehealth stocks
Tech Stocks

Well Health Stock: Buy, Sell, or Hold?

Another record-breaking quarter and strong demand sets the stage for continued momentum for Well Health stock.

Read more »

3 colorful arrows racing straight up on a black background.
Dividend Stocks

TSX Stocks Soaring Higher With No Signs of Slowing

Three TSX stocks continue to beat the market and could soar higher in an improving investment landscape.

Read more »

profit rises over time
Tech Stocks

2 Non-AI Tech Stocks to Buy in November for Better Returns

Not all AI stocks are riding the hype train, and for many investors, well-understood and predictable growth stocks might be…

Read more »

worry concern
Tech Stocks

In a Few Years, You’ll Probably Regret Not Owning BlackBerry Stock

Here’s why I believe BlackBerry could be one of the most overlooked Canadian tech stocks right now.

Read more »

A worker uses a double monitor computer screen in an office.
Tech Stocks

Is Constellation Software Stock a Buy for its 0.25% Dividend Yield?

Here's what investors may want to consider when it comes to Dollarama (TSX:DOL) and its relatively low dividend yield.

Read more »

Nurse talks with a teenager about medication
Tech Stocks

Shares of WELL Health Just Zoomed. Is It a Buy?

Given its improving financials and healthy growth prospects, WELL Health could deliver superior returns over the next three years.

Read more »